-
Hyperimmune Globulin for Severely Immunocompromised Patients Hospitalized With Coronavirus Disease 2019: a randomized, controlled trial
Huygens, S., Hofsink, Q., Nijhof, I. S., Goorhuis, A., Kater, A. P., Te Boekhorst, P. A., Swaneveld, F., Novotný, V. M., Bogers, S., Welkers, M. R., Papageorgiou, G., Rijnders, B. J. & Heijmans, J., 15 Jan 2023, In: The Journal of Infectious Diseases. 227, 2, p. 206-210 5 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Antibody Response in Immunocompromised Patients With Hematologic Cancers Who Received a 3-Dose mRNA-1273 Vaccination Schedule for COVID-19
COBRA KAI Study Team, 1 Oct 2022, In: JAMA oncology. 8, 10, p. 1477-1483 7 p.Research output: Contribution to journal › Article › Academic › peer-review
-
COVID-19-VACCINATIE BIJ IMMUUNGECOMPROMITTEERDE PATIËNTEN MET HEMATOLOGISCHE AANDOENINGEN
Haggenburg, S., Goorhuis, A., Hofsink, Q., Hazenberg, M. D., Rutten, C. E. & Nijhof, I. S., Jul 2022, In: Nederlands tijdschrift voor hematologie.Research output: Contribution to journal › Review article › Academic › peer-review
- All publications
